Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: A link between inflammation, atherosclerosis, and thrombosis

Frontiers in Pharmacology

Volumn 7, Issue AUG, 2016, Pages

  Badimon, Lina ^a,b   Suades, Rosa ^a   Fuentes, Eduardo ^c,d   Palomo, Iván ^c,d   Padró, Teresa ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSIDAD DE TALCA   (Chile)

^d Centro de Estudios en Alimentos Procesados (CEAP)   (Chile)

Author keywords

Atherosclerosis; Cardiovascular diseases; Cell derived microvesicles; Inflammation; Platelets; Thrombosis

Indexed keywords

CD40 LIGAND; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; RANTES; VON WILLEBRAND FACTOR;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; HUMAN; LEUKOCYTE AGGREGATION; MEMBRANE MICROPARTICLE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOSIS;

EID: 84988731987     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00293     Document Type: Review

References (215)

1. Aatonen, M., Gronholm, M., and Siljander, P. R. (2012). Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin. Thromb. Hemost. 38, 102-113. doi: 10.1055/s-0031-1300956
2. Aatonen, M. T., Ohman, T., Nyman, T. A., Laitinen, S., Gronholm, M., and Siljander, P. R. (2014). Isolation and characterization of platelet-derived extracellular vesicles. J. Extracell. Vesicles 3, 24692. doi: 10.3402/jev.v3.24692
3. Abdel-Monem, H., Dasgupta, S. K., Le, A., Prakasam, A., and Thiagarajan, P. (2010). Phagocytosis of platelet microvesicles and beta2-glycoprotein I. Thromb. Haemost. 104, 335-341. doi: 10.1160/TH09-12-0849
4. Aleman, M. M., Gardiner, C., Harrison, P., and Wolberg, A. S. (2011). Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J. Thromb. Haemost. 9, 2251-2261. doi: 10.1111/j.1538-7836.2011.04488.x
5. Ando, M., Iwata, A., Ozeki, Y., Tsuchiya, K., Akiba, T., and Nihei, H. (2002). Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int. 62, 1757-1763. doi: 10.1046/j.1523-1755.2002.00627.x
6. Ayers, L., Nieuwland, R., Kohler, M., Kraenkel, N., Ferry, B., and Leeson, P. (2015). Dynamic microvesicle release and clearance within the cardiovascular system: triggers and mechanisms. Clin. Sci. (Lond.) 129, 915-931. doi: 10.1042/CS20140623
7. Azevedo, L. C., Pedro, M. A., and Laurindo, F. R. (2007). Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov. 2, 41-51. doi: 10.2174/157489007779606121
8. Badimon, L., and Vilahur, G. (2014). Thrombosis formation on atherosclerotic lesions and plaque rupture. J. Intern. Med. 276, 618-632. doi: 10.1111/joim.12296
9. Baj-Krzyworzeka, M., Majka, M., Pratico, D., Ratajczak, J., Vilaire, G., Kijowski, J., et al. (2002). Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp. Hematol. 30, 450-459. doi: 10.1016/S0301-472X(02)00791-9
10. Barry, O. P., Kazanietz, M. G., Pratico, D., and FitzGerald, G. A. (1999). Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 274, 7545-7556. doi: 10.1074/jbc.274.11.7545
11. Barry, O. P., Pratico, D., Lawson, J. A., and FitzGerald, G. A. (1997). Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Invest. 99, 2118-2127. doi: 10.1172/JCI119385
12. Barry, O. P., Pratico, D., Savani, R. C., and FitzGerald, G. A. (1998). Modulation of monocyte-endothelial cell interactions by platelet microparticles. J. Clin. Invest. 102, 136-144. doi: 10.1172/JCI2592
13. Bastos-Amador, P., Royo, F., Gonzalez, E., Conde-Vancells, J., Palomo-Diez, L., Borras, F. E., et al. (2012). Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. J. Proteomics 75, 3574-3584. doi: 10.1016/j.jprot.2012.03.054
14. Battinelli, E. M., Markens, B. A., and Italiano, J. E. Jr. (2011). Release of angiogenesis regulatory proteins from plateletalpha granules: modulation of physiologic and pathologic angiogenesis. Blood 118, 1359-1369. doi: 10.1182/blood-2011-02-334524
15. Berckmans, R. J., Nieuwland, R., Boing, A. N., Romijn, F. P., Hack, C. E., and Sturk, A. (2001). Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 85, 639-646.
16. Biasucci, L. M., Porto, I., Di Vito, L., De Maria, G. L., Leone, A. M., Tinelli, G., et al. (2012). Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ. J. 76, 2174-2182. doi: 10.1253/circj.CJ-12-0068
17. Biro, E., Akkerman, J. W., Hoek, F. J., Gorter, G., Pronk, L. M., Sturk, A., et al. (2005). The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions. J. Thromb. Haemost. 3, 2754-2763. doi: 10.1111/j.1538-7836.2005.01646.x
18. Boilard, E., Nigrovic, P. A., Larabee, K., Watts, G. F., Coblyn, J. S., Weinblatt, M. E., et al. (2010). Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327, 580-583. doi: 10.1126/science.1181928
19. Boing, A. N., Hau, C. M., Sturk, A., and Nieuwland, R. (2008). Platelet microparticles contain active caspase 3. Platelets 19, 96-103. doi: 10.1080/09537100701777295
20. Boudreau, L. H., Duchez, A. C., Cloutier, N., Soulet, D., Martin, N., Bollinger, J., et al. (2014). Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 124, 2173-2183. doi: 10.1182/blood-2014-05-573543
21. Brill, A., Dashevsky, O., Rivo, J., Gozal, Y., and Varon, D. (2005). Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc. Res. 67, 30-38. doi: 10.1016/j.cardiores.2005.04.007
22. Brown, G. T., and McIntyre, T. M. (2011). Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1beta-rich microparticles. J. Immunol. 186, 5489-5496. doi: 10.4049/jimmunol.1001623
23. Brunetti, M., Martelli, N., Manarini, S., Mascetra, N., Musiani, P., Cerletti, C., et al. (2000). Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators, role of TGFbeta-1. Thromb. Haemost. 84, 478-483.
24. Bulut, D., Becker, V., and Mugge, A. (2011). Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Can. J. Physiol. Pharmacol. 89, 239-244. doi: 10.1139/y11-013
25. + microparticles in healthy offsprings of patients with coronary artery disease. Eur. J. Clin. Invest. 39, 17-22. doi: 10.1111/j.1365-2362.2008.02058.x
26. Butenas, S., Bouchard, B. A., Brummel-Ziedins, K. E., Parhami-Seren, B., and Mann, K. G. (2005). Tissue factor activity in whole blood. Blood 105, 2764-2770. doi: 10.1182/blood-2004-09-3567
27. Caby, M. P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., and Bonnerot, C. (2005). Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17, 879-887. doi: 10.1093/intimm/dxh267
28. Camera, M., Brambilla, M., Toschi, V., and Tremoli, E. (2010). Tissue factor expression on platelets is a dynamic event. Blood 116, 5076-5077. doi: 10.1182/blood-2010-09-307306
29. Campello, E., Spiezia, L., Radu, C. M., Dhima, S., Visentin, S., Valle, F. D., et al. (2015). Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia. Thromb. Res. 136, 427-431. doi: 10.1016/j.thromres.2015.05.029
30. Cauwenberghs, S., Feijge, M. A., Harper, A. G., Sage, S. O., Curvers, J., and Heemskerk, J. W. (2006). Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett. 580, 5313-5320. doi: 10.1016/j.febslet.2006.08.082
31. Chaturvedi, S., Cockrell, E., Espinola, R., Hsi, L., Fulton, S., Khan, M., et al. (2015). Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Thromb. Res. 135, 102-108. doi: 10.1016/j.thromres.2014.11.011
32. Chen, Y. L., Chen, C. H., Wallace, C. G., Wang, H. T., Yang, C. C., and Yip, H. K. (2014). Levels of circulating microparticles in patients with chronic cardiorenal disease. J. Atheroscler. Thromb. 22, 247-256. doi: 10.5551/jat.26658
33. 45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts. Thromb. Haemost. 116, 103-114. doi: 10.1160/TH16-02-0130
34. Chiva-Blanch, G., Suades, R., Crespo, J., Pena, E., Padro, T., Jimenez-Xarrie, E., et al. (2016b). Microparticle shedding from neural progenitor cells and vascular compartment cells is increased in ischemic stroke. PLoS ONE 11:e0148176. doi: 10.1371/journal.pone.0148176
35. 45(+) and SMA-alpha(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. Int. J. Cardiol. 208, 147-149. doi: 10.1016/j.ijcard.2016.01.211
36. Chiva-Blanch, G., Suades, R., Padro, T., Vilahur, G., Pena, E., Ybarra, J., et al. (2016d). Microparticle shedding by erythrocytes, monocytes and vascular smooth muscular cells is reduced by aspirin in diabetic patients. Rev. Esp. Cardiol. (Engl. Ed.) 69, 672-680. doi: 10.1016/j.rec.2015.12.033
37. Chou, J., Mackman, N., Merrill-Skoloff, G., Pedersen, B., Furie, B. C., and Furie, B. (2004). Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104, 3190-3197. doi: 10.1182/blood-2004-03-0935
38. Chou, Y. I., Kong, J., Song, R., Yan, L., Zheng, L., and Zhang, Y. (2014). Correlations of platelet-derived microparticles with thromboxane B2, platelet-activating factor, endothelin-1, and neutrophil to lymphocyte ratio in patients with coronary intermediate lesions. Biomarkers 19, 684-692. doi: 10.3109/1354750X.2014.981293
39. Chung, A. W., Radomski, A., Alonso-Escolano, D., Jurasz, P., Stewart, M. W., Malinski, T., et al. (2004). Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases. Br. J. Pharmacol. 143, 845-855. doi: 10.1038/sj.bjp.0705997
40. Chung, J., Suzuki, H., Tabuchi, N., Sato, K., Shibamiya, A., and Koyama, T. (2007). Identification of tissue factor and platelet-derived particles on leukocytes during cardiopulmonary bypass by flow cytometry and immunoelectron microscopy. Thromb. Haemost. 98, 368-374.
41. Cloutier, N., Tan, S., Boudreau, L. H., Cramb, C., Subbaiah, R., Lahey, L., et al. (2013). The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol. Med. 5, 235-249. doi: 10.1002/emmm.201201846
42. Connor, D. E., Exner, T., Ma, D. D., and Joseph, J. E. (2009). Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul. Fibrinolysis 20, 558-564. doi: 10.1097/MBC.0b013e32832ee915
43. Connor, D. E., Exner, T., Ma, D. D., and Joseph, J. E. (2010). The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb. Haemost. 103, 1044-1052. doi: 10.1160/TH09-09-0644
44. Csongrádi,É, Nagy, B. Jr., Fulop, T., Varga, Z., Karányi, Z., Magyar, M. T., et al. (2011). Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thromb. Haemost. 106, 683-692. doi: 10.1160/TH11-01-0030
45. Cui, Y., Zheng, L., Jiang, M., Jia, R., Zhang, X., Quan, Q., et al. (2013). Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Mol. Biol. Rep. 40, 6437-6442. doi: 10.1007/s11033-013-2758-1
46. Dasgupta, S. K., Abdel-Monem, H., Niravath, P., Le, A., Bellera, R. V., Langlois, K., et al. (2009). Lactadherin and clearance of platelet-derived microvesicles. Blood 113, 1332-1339. doi: 10.1182/blood-2008-07-167148
47. Dean, W. L., Lee, M. J., Cummins, T. D., Schultz, D. J., and Powell, D. W. (2009). Proteomic and functional characterisation of platelet microparticle size classes. Thromb. Haemost. 102, 711-718. doi: 10.1160/TH09-04-243
48. Dinkla, S., van Cranenbroek, B., van der Heijden, W. A., He, X., Wallbrecher, R., Dumitriu, I. E., et al. (2016). Platelet-derived microparticles inhibit IL-17 production by regulatory T cells through P-selectin. Blood 127, 1976-1986. doi: 10.1182/blood-2015-04-640300
49. Eckstein, F. M., Xiang, W., Weiss, D. R., Zimmermann, R., and Strasser, E. F. (2014). The influence of pre-analytical conditions on platelet-derived microparticles. Clin. Lab. 60, 707-716.
50. Escolar, G., Lopez-Vilchez, I., Diaz-Ricart, M., White, J. G., and Galan, A. M. (2008). Internalization of tissue factor by platelets. Thromb. Res. 122(Suppl. 1), S37-S41. doi: 10.1016/S0049-3848(08)70017-3
51. Flaumenhaft, R. (2006). Formation and fate of platelet microparticles. Blood Cells Mol. Dis. 36, 182-187. doi: 10.1016/j.bcmd.2005.12.019
52. Flaumenhaft, R., Dilks, J. R., Richardson, J., Alden, E., Patel-Hett, S. R., Battinelli, E., et al. (2009). Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 113, 1112-1121. doi: 10.1182/blood-2008-06-163832
53. Forlow, S. B., McEver, R. P., and Nollert, M. U. (2000). Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 95, 1317-1323.
54. Franca, C. N., Pinheiro, L. F., Izar, M. C., Brunialti, M. K., Salomao, R., Bianco, H. T., et al. (2012). Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. Circ. J. 76, 729-736. doi: 10.1253/circj.CJ-11-1145
55. Fuentes, Q. E., Fuentes, Q. F., Andres, V., Pello, O. M., de Mora, J. F., and Palomo, G. I. (2013). Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 24, 255-262. doi: 10.3109/09537104.2012.690113
56. Fuster, V., Stein, B., Ambrose, J. A., Badimon, L., Badimon, J. J., and Chesebro, J. H. (1990). Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82(3Suppl.), II47-II59.
57. Gambim, M. H., do Carmo Ade, O., Marti, L., Verissimo-Filho, S., Lopes, L. R., and Janiszewski, M. (2007). Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit. Care 11, R107. doi: 10.1186/cc6133
58. Garcia, B. A., Smalley, D. M., Cho, H., Shabanowitz, J., Ley, K., and Hunt, D. F. (2005). The platelet microparticle proteome. J. Proteome Res. 4, 1516-1521. doi: 10.1021/pr0500760
59. Gatsiou, A., Boeckel, J. N., Randriamboavonjy, V., and Stellos, K. (2012). MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Curr. Vasc. Pharmacol. 10, 524-531. doi: 10.2174/157016112801784611
60. Gemmell, C. H., Sefton, M. V., and Yeo, E. L. (1993). Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J. Biol. Chem. 268, 14586-14589.
61. Gemmell, C. H., Yeo, E. L., and Sefton, M. V. (1997). Flow cytometric analysis of material-induced platelet activation in a canine model: elevated microparticle levels and reduced platelet life span. J. Biomed. Mater. Res. 37, 176-181. doi: 10.1002/(SICI)1097-4636(199711)37:2<176::AID-JBM5>3.0.CO;2-O
62. George, M., Ganesh, M. R., Sridhar, A., Jena, A., Rajaram, M., Shanmugam, E., et al. (2015). Evaluation of endothelial and platelet derived microparticles in patients with acute coronary syndrome. J. Clin. Diagn. Res. 9, OC09-OC13. doi: 10.7860/JCDR/2015/14493.6920
63. Getts, D. R., Terry, R. L., Getts, M. T., Deffrasnes, C., Muller, M., van Vreden, C., et al. (2014). Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci. Transl. Med. 6, 219ra217. doi: 10.1126/scitranslmed.3007563
64. Gidlof, O., van der Brug, M., Ohman, J., Gilje, P., Olde, B., Wahlestedt, C., et al. (2013). Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 121, 3908-3917. doi: 10.1182/blood-2012-10-461798
65. Gilbert, G. E., Sims, P. J., Wiedmer, T., Furie, B., Furie, B. C., and Shattil, S. J. (1991). Platelet-derived microparticles express high affinity receptors for factor VIII. J. Biol. Chem. 266, 17261-17268.
66. Gitz, E., Pollitt, A. Y., Gitz-Francois, J. J., Alshehri, O., Mori, J., Montague, S., et al. (2014). CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood 124, 2262-2270. doi: 10.1182/blood-2014-05-572818
67. Goto, S., Tamura, N., Li, M., Handa, M., Ikeda, Y., Handa, S., et al. (2003). Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J. Thromb. Haemost. 1, 2022-2030. doi: 10.1046/j.1538-7836.2003.00349.x
68. Goudevenos, J., Tselepis, A. D., Vini, M. P., Michalis, L., Tsoukatos, D. C., Elisaf, M., et al. (2001). Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty. Eur. J. Clin. Invest. 31, 15-23. doi: 10.1046/j.1365-2362.2001.00782.x
69. Grant, R., Ansa-Addo, E., Stratton, D., Antwi-Baffour, S., Jorfi, S., Kholia, S., et al. (2011). A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma. J. Immunol. Methods 371, 143-151. doi: 10.1016/j.jim.2011.06.024
70. Gustafson, C. M., Shepherd, A. J., Miller, V. M., and Jayachandran, M. (2015). Age-and sex-specific differences in blood-borne microvesicles from apparently healthy humans. Biol. Sex Differ. 6, 10. doi: 10.1186/s13293-015-0028-8
71. Hayon, Y., Dashevsky, O., Shai, E., Brill, A., Varon, D., and Leker, R. R. (2012). Platelet microparticles induce angiogenesis and neurogenesis after cerebral ischemia. Curr. Neurovasc. Res. 9, 185-192. doi: 10.2174/156720212801619018
72. Heijnen, H. F., Schiel, A. E., Fijnheer, R., Geuze, H. J., and Sixma, J. J. (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791-3799.
73. Helal, O., Defoort, C., Robert, S., Marin, C., Lesavre, N., Lopez-Miranda, J., et al. (2011). Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr. Metab. Cardiovasc. Dis. 21, 665-671. doi: 10.1016/j.numecd.2010.01.004
74. Herring, J. M., McMichael, M. A., and Smith, S. A. (2013). Microparticles in health and disease. J. Vet. Intern. Med. 27, 1020-1033. doi: 10.1111/jvim.12128
75. Holme, P. A., Brosstad, F., and Solum, N. O. (1993). The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation. Thromb. Haemost. 70, 681-686.
76. Horigome, H., Hiramatsu, Y., Shigeta, O., Nagasawa, T., and Matsui, A. (2002). Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J. Am. Coll. Cardiol. 39, 1072-1077. doi: 10.1016/S0735-1097(02)01718-7
77. Horn, P., Baars, T., Kahlert, P., Heiss, C., Westenfeld, R., Kelm, M., et al. (2015). Release of intracoronary microparticles during stent implantation into stable atherosclerotic lesions under protection with an aspiration device. PLoS ONE 10:e0124904. doi: 10.1371/journal.pone.0124904
78. Horstman, L. L., and Ahn, Y. S. (1999). Platelet microparticles: a wide-angle perspective. Crit. Rev. Oncol. Hematol. 30, 111-142. doi: 10.1016/S1040-8428(98)00044-4
79. Hristov, M., Erl, W., Linder, S., and Weber, P. C. (2004). Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104, 2761-2766. doi: 10.1182/blood-2003-10-3614
80. Hugel, B., Socie, G., Vu, T., Toti, F., Gluckman, E., Freyssinet, J. M., et al. (1999). Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 93, 3451-3456.
81. Hulsmans, M., and Holvoet, P. (2013). MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc. Res. 100, 7-18. doi: 10.1093/cvr/cvt161
82. Inoue, T., Hikichi, Y., Morooka, T., Yoshida, K., Fujimatsu, D., Komoda, H., et al. (2006). Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation. Platelets 17, 416-420. doi: 10.1080/09537100600757885
83. Inoue, T., Komoda, H., Kotooka, N., Morooka, T., Fujimatsu, D., Hikichi, Y., et al. (2008). Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation. Atherosclerosis 196, 469-476. doi: 10.1016/j.atherosclerosis.2006.12.004
84. Ismail, E. A., and Youssef, O. I. (2012). Platelet-derived microparticles and platelet function profile in children with congenital heart disease. Clin. Appl. Thromb. Hemost. 19, 424-432. doi: 10.1177/1076029612456733
85. Italiano, J. E. Jr., Richardson, J. L., Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., et al. (2008). Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate plateletalpha granules and differentially released. Blood 111, 1227-1233. doi: 10.1182/blood-2007-09-113837
86. Iwamoto, S., Kawasaki, T., Kambayashi, J., Ariyoshi, H., and Monden, M. (1996). Platelet microparticles: a carrier of platelet-activating factor? Biochem. Biophys. Res. Commun. 218, 940-944. doi: 10.1006/bbrc.1996.0166
87. Janiszewski, M., Do Carmo, A. O., Pedro, M. A., Silva, E., Knobel, E., and Laurindo, F. R. (2004). Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway. Crit. Care Med. 32, 818-825. doi: 10.1097/01.CCM.0000114829.17746.19
88. Jayachandran, M., Litwiller, R. D., Owen, W. G., Heit, J. A., Behrenbeck, T., Mulvagh, S. L., et al. (2008). Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am. J. Physiol. Heart Circ. Physiol. 295, H931-H938. doi: 10.1152/ajpheart.00193.2008
89. Jimenez, J. J., Jy, W., Mauro, L. M., Soderland, C., Horstman, L. L., and Ahn, Y. S. (2003). Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb. Res. 109, 175-180. doi: 10.1016/S0049-3848(03)00064-1
90. Juan-Babot, J. O., Martinez-Gonzalez, J., Berrozpe, M., and Badimon, L. (2003). [Neovascularization in human coronary arteries with lesions of different severity]. Rev. Esp. Cardiol. 56, 978-986. doi: 10.1016/S0300-8932(03)76995-4
91. Judge, H. M., Buckland, R. J., Sugidachi, A., Jakubowski, J. A., and Storey, R. F. (2010). Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function. Thromb. Haemost. 103, 1210-1217. doi: 10.1160/TH09-11-0770
92. Jung, C., Sorensson, P., Saleh, N., Arheden, H., Ryden, L., and Pernow, J. (2012). Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 221, 226-231. doi: 10.1016/j.atherosclerosis.2011.12.025
93. Jy, W., Mao, W. W., Horstman, L., Tao, J., and Ahn, Y. S. (1995). Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol. Dis. 21, 217-231. doi: 10.1006/bcmd.1995.0025
94. Kagawa, H., Nomura, S., Nagahama, M., Ozaki, Y., and Fukuhara, S. (2001). Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia. Clin. Appl. Thromb. Hemost. 7, 153-157. doi: 10.1177/107602960100700213
95. Kahner, B. N., Dorsam, R. T., and Kunapuli, S. P. (2008). Role of P2Y receptor subtypes in platelet-derived microparticle generation. Front. Biosci. 13:433-439. doi: 10.2741/2690
96. 40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol. 16, 225-231.
97. Kawamoto, A., Tkebuchava, T., Yamaguchi, J., Nishimura, H., Yoon, Y. S., Milliken, C., et al. (2003). Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107, 461-468. doi: 10.1161/01.CIR.0000046450.89986.50
98. Kim, H. K., Song, K. S., Chung, J. H., Lee, K. R., and Lee, S. N. (2004). Platelet microparticles induce angiogenesis in vitro. Br. J. Haematol. 124, 376-384. doi: 10.1046/j.1365-2141.2003.04773.x
99. Kuriyama, N., Nagakane, Y., Hosomi, A., Ohara, T., Kasai, T., Harada, S., et al. (2010). Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction. Clin. Appl. Thromb. Hemost. 16, 26-32. doi: 10.1177/1076029609338047
100. Laffont, B., Corduan, A., Ple, H., Duchez, A. C., Cloutier, N., Boilard, E., et al. (2013). Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 122, 253-261. doi: 10.1182/blood-2013-03-492801
101. Leroyer, A. S., Isobe, H., Leseche, G., Castier, Y., Wassef, M., Mallat, Z., et al. (2007). Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol. 49, 772-777. doi: 10.1016/j.jacc.2006.10.053
102. Lin, H. C., Chang, H. W., Hsiao, S. H., Chou, M. L., Seghatchian, J., and Burnouf, T. (2015). Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro. Transfus. Apher. Sci. 53, 246-252. doi: 10.1016/j.transci.2015.10.002
103. Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., et al. (2001). Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J. Cell Biol. 154, 485-490. doi: 10.1083/jcb.200105058
104. Lopez-Vilchez, I., Escolar, G., Diaz-Ricart, M., Fuste, B., Galan, A. M., and White, J. G. (2007). Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa. Thromb. Haemost. 97, 202-211.
105. Lopez-Vilchez, I., Galan, A. M., Hernandez, M. R., Caballo, C., Roque, M., Diaz-Ricart, M., et al. (2012). Platelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro. Thromb. Res. 130, e294-e300. doi: 10.1016/j.thromres.2012.10.003
106. Lösche, W., Scholz, T., Temmler, U., Oberle, V., and Claus, R. A. (2004). Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets 15, 109-115. doi: 10.1080/09537100310001649885
107. Losito, I., Conte, E., Cataldi, T. R., Cioffi, N., Megli, F. M., and Palmisano, F. (2015). The phospholipidomic signatures of human blood microparticles, platelets and platelet-derived microparticles: a comparative HILIC-ESI-MS investigation. Lipids 50, 71-84. doi: 10.1007/s11745-014-3975-7
108. Lubsczyk, B., Kollars, M., Hron, G., Kyrle, P. A., Weltermann, A., and Gartner, V. (2010). Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans. Eur. J. Clin. Invest. 40, 477-482. doi: 10.1111/j.1365-2362.2010.02299.x
109. Lukasik, M., Rozalski, M., Luzak, B., Michalak, M., Ambrosius, W., Watala, C., et al. (2013). Enhanced platelet-derived microparticle formation is associated with carotid atherosclerosis in convalescent stroke patients. Platelets 24, 63-70. doi: 10.3109/09537104.2011.654292
110. Ma, F., Liu, H., Shen, Y., Zhang, Y., and Pan, S. (2015). Platelet-derived microvesicles are involved in cardio-protective effects of remote preconditioning. Int. J. Clin. Exp. Pathol. 8, 10832-10839.
111. Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B., and de Faire, U. (1994). Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 330, 1041-1046. doi: 10.1056/NEJM199404143301503
112. Mause, S. F. (2013). Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis. Thromb. Haemost. 109, 5-6. doi: 10.1160/TH12-11-0817
113. Mause, S. F., Ritzel, E., Liehn, E. A., Hristov, M., Bidzhekov, K., Muller-Newen, G., et al. (2010). Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 122, 495-506. doi: 10.1161/CIRCULATIONAHA.109.909473
114. Mause, S. F., von Hundelshausen, P., Zernecke, A., Koenen, R. R., and Weber, C. (2005). Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler. Thromb. Vasc. Biol. 25, 1512-1518. doi: 10.1161/01.ATV.0000170133.43608.37
115. McCarthy, M. J., Loftus, I. M., Thompson, M. M., Jones, L., London, N. J., Bell, P. R., et al. (1999). Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J. Vasc. Surg. 30, 261-268. doi: 10.1016/S0741-5214(99)70136-9
116. Merten, M., Pakala, R., Thiagarajan, P., and Benedict, C. R. (1999). Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 99, 2577-2582. doi: 10.1161/01.CIR.99.19.2577
117. Meziani, F., Tesse, A., and Andriantsitohaina, R. (2008). Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol. Rep. 60, 75-84.
118. Michelsen, A. E., Brodin, E., Brosstad, F., and Hansen, J. B. (2008). Increased level of platelet microparticles in survivors of myocardial infarction. Scand. J. Clin. Lab. Invest. 68, 386-392. doi: 10.1080/00365510701794957
119. Milioli, M., Ibanez-Vea, M., Sidoli, S., Palmisano, G., Careri, M., and Larsen, M. R. (2015). Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when stimulated by different physiological agonists. J. Proteomics 121, 56-66. doi: 10.1016/j.jprot.2015.03.013
120. Mitsios, J. V., Vini, M. P., Stengel, D., Ninio, E., and Tselepis, A. D. (2006). Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles. Arterioscler. Thromb. Vasc. Biol. 26, 1907-1913. doi: 10.1161/01.ATV.0000228821.79588.ef
121. Miyazaki, Y., Nomura, S., Miyake, T., Kagawa, H., Kitada, C., Taniguchi, H., et al. (1996). High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 88, 3456-3464.
122. Miyazono, K., Okabe, T., Urabe, A., Yamanaka, M., and Takaku, F. (1985). A platelet factor that stimulates the proliferation of vascular endothelial cells. Biochem. Biophys. Res. Commun. 126, 83-88. doi: 10.1016/0006-291X(85)90574-1
123. Mobarrez, F., He, S., Broijersen, A., Wiklund, B., Antovic, A., Antovic, J., et al. (2011). Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb. Haemost. 106, 344-352. doi: 10.1160/TH10-12-0810
124. Monkovic, D. D., and Tracy, P. B. (1990). Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J. Biol. Chem. 265, 17132-17140.
125. Montoro-Garcia, S., Shantsila, E., Hernandez-Romero, D., Jover, E., Valdes, M., Marin, F., et al. (2014). Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. Br. J. Haematol. 166, 571-580. doi: 10.1111/bjh.12913
126. Morel, O., Hugel, B., Jesel, L., Mallat, Z., Lanza, F., Douchet, M. P., et al. (2004). Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J. Thromb. Haemost. 2, 1118-1126. doi: 10.1111/j.1538-7836.2004.00805.x
127. Morel, O., Jesel, L., Hugel, B., Douchet, M. P., Zupan, M., Chauvin, M., et al. (2003). Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles. J. Thromb. Haemost. 1, 171-177. doi: 10.1046/j.1538-7836.2003.00010.x
128. Mujica, V., Urzua, A., Leiva, E., Diaz, N., Moore-Carrasco, R., Vasquez, M., et al. (2010). Intervention with education and exercise reverses the metabolic syndrome in adults. J. Am. Soc. Hypertens. 4, 148-153. doi: 10.1016/j.jash.2010.02.008
129. Murakami, T., Horigome, H., Tanaka, K., Nakata, Y., Ohkawara, K., Katayama, Y., et al. (2007). Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb. Res. 119, 45-53. doi: 10.1016/j.thromres.2005.12.013
130. Namba, M., Tanaka, A., Shimada, K., Ozeki, Y., Uehata, S., Sakamoto, T., et al. (2007). Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood. Arterioscler. Thromb. Vasc. Biol. 27, 255-256. doi: 10.1161/01.ATV.0000252064.97632.2c
131. Nebor, D., Bowers, A., Connes, P., Hardy-Dessources, M. D., Knight-Madden, J., Cumming, V., et al. (2014). Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia. PLoS ONE 9:e87243. doi: 10.1371/journal.pone.0087243
132. Nishijima, K., Kiryu, J., Tsujikawa, A., Miyamoto, K., Honjo, M., Tanihara, H., et al. (2004). Platelets adhering to the vascular wall mediate postischemic leukocyte-endothelial cell interactions in retinal microcirculation. Invest. Ophthalmol. Vis. Sci. 45, 977-984. doi: 10.1167/iovs.03-0526
133. Nomura, S., Nakamura, T., Cone, J., Tandon, N. N., and Kambayashi, J. (2000). Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry 40, 173-181. doi: 10.1002/1097-0320(20000701)40:3<173::AID-CYTO1>3.0.CO;2-L
134. Nomura, S., Omoto, S., Yokoi, T., Fujita, S., Ozasa, R., Eguchi, N., et al. (2011). Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus. Int. J. Gen. Med. 4, 539-545. doi: 10.2147/IJGM.S22115
135. Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., Fukuhara, S., and Iwasaka, T. (2004a). Losartan and simvastatin inhibit platelet activation in hypertensive patients. J. Thromb. Thrombolysis 18, 177-185. doi: 10.1007/s11239-005-0343-8
136. Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., Iwasaka, T., and Fukuhara, S. (2004b). Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin. Appl. Thromb. Hemost. 10, 205-215. doi: 10.1177/107602960401000302
137. Nomura, S., Takahashi, N., Inami, N., Kajiura, T., Yamada, K., Nakamori, H., et al. (2004c). Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis 174, 329-335. doi: 10.1016/j.atherosclerosis.2004.01.027
138. Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., and Iwasaka, T. (2005a). Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus. J. Hum. Hypertens. 19, 551-557. doi: 10.1038/sj.jhh.1001863
139. Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., and Iwasaka, T. (2005b). Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus. Thromb. Res. 115, 277-285. doi: 10.1016/j.thromres.2004.08.015
140. Nomura, S., Suzuki, M., Katsura, K., Xie, G. L., Miyazaki, Y., Miyake, T., et al. (1995). Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 116, 235-240. doi: 10.1016/0021-9150(95)05551-7
141. Nomura, S., Tandon, N. N., Nakamura, T., Cone, J., Fukuhara, S., and Kambayashi, J. (2001). High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 158, 277-287. doi: 10.1016/S0021-9150(01)00433-6
142. Oberle, V., Fischer, A., Setzer, F., and Losche, W. (2007). Thrombus formation without platelets under inflammatory condition: an in vitro study. Platelets 18, 143-149. doi: 10.1080/09537100600935176
143. Ohtsuka, M., Sasaki, K., Ueno, T., Seki, R., Nakayoshi, T., Koiwaya, H., et al. (2013). Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis 227, 275-282. doi: 10.1016/j.atherosclerosis.2013.01.040
144. Ohuchi, M., Fujino, K., Kishimoto, T., Yamane, T., Hamamoto, T., Tabata, T., et al. (2015). Association of the plasma platelet-derived microparticles to platelet count ratio with hospital mortality and disseminated intravascular coagulopathy in critically lll patients. J. Atheroscler. Thromb. 22, 773-782. doi: 10.5551/jat.29439
145. Ottaviani, L., De Windt, L. J., and da Costa Martins, P. A. (2016). Exosomes: scytales in the damaged heart. Ann. Transl. Med. 4, 222. doi: 10.21037/atm.2016.05.17
146. Owens, M. R. (1994). The role of platelet microparticles in hemostasis. Transfus. Med. Rev. 8, 37-44. doi: 10.1016/S0887-7963(94)70096-1
147. Pakala, R. (2004). Serotonin and thromboxane A2 stimulate platelet-derived microparticle-induced smooth muscle cell proliferation. Cardiovasc. Radiat. Med. 5, 20-26. doi: 10.1016/j.carrad.2003.12.002
148. Palomo, I., Toro, C., and Alarcon, M. (2008). The role of platelets in the pathophysiology of atherosclerosis (Review). Mol. Med. Rep. 1, 179-184.
149. Palomo, I. F., Torres, G. I., Alarcon, M. A., Maragano, P. J., Leiva, E., and Mujica, V. (2006). [High prevalence of classic cardiovascular risk factors in a population of university students from south central Chile]. Rev. Esp. Cardiol. 59, 1099-1105. doi: 10.1157/13095778
150. Pasquet, J. M., Dachary-Prigent, J., and Nurden, A. T. (1996). Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur. J. Biochem. 239, 647-654. doi: 10.1111/j.1432-1033.1996.0647u.x
151. Pawelczyk, M., Chmielewski, H., Kaczorowska, B., Przybyla, M., and Baj, Z. (2015). The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke. Arch. Med. Sci. 11, 115-121. doi: 10.5114/aoms.2015.49216
152. Perez-Pujol, S., Marker, P. H., and Key, N. S. (2007). Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A 71, 38-45. doi: 10.1002/cyto.a.20354
153. 40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc. Natl. Acad. Sci. U.S.A. 100, 12367-12371. doi: 10.1073/pnas.2032886100
154. Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., et al. (2003). Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41, 211-217. doi: 10.1161/01.HYP.0000049760.15764.2D
155. Prokopi, M., Pula, G., Mayr, U., Devue, C., Gallagher, J., Xiao, Q., et al. (2009). Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114, 723-732. doi: 10.1182/blood-2009-02-205930
156. Ramacciotti, E., Hawley, A. E., Farris, D. M., Ballard, N. E., Wrobleski, S. K., Myers, D. D., et al. (2009). Leukocyte-and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb. Haemost. 101, 748-754. doi: 10.1160/TH08-09-0620
157. Rand, M. L., Wang, H., Bang, K. W., Packham, M. A., and Freedman, J. (2006). Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J. Thromb. Haemost. 4, 1621-1623. doi: 10.1111/j.1538-7836.2006.02011.x
158. Rank, A., Nieuwland, R., Delker, R., Kohler, A., Toth, B., Pihusch, V., et al. (2010). Cellular origin of platelet-derived microparticles in vivo. Thromb Res 126, e255-e259. doi: 10.1016/j.thromres.2010.07.012
159. Raturi, A., Miersch, S., Hudson, J. W., and Mutus, B. (2008). Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. Biochim. Biophys. Acta 1778, 2790-2796. doi: 10.1016/j.bbamem.2008.07.003
160. Ray, D. M., Spinelli, S. L., Pollock, S. J., Murant, T. I., O'Brien, J. J., Blumberg, N., et al. (2008). Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb. Haemost. 99, 86-95. doi: 10.1160/TH07-05-0328
161. Reininger, A. J., Heijnen, H. F., Schumann, H., Specht, H. M., Schramm, W., and Ruggeri, Z. M. (2006). Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 107, 3537-3545. doi: 10.1182/blood-2005-02-0618
162. Ren, J. G., Man, Q. W., Zhang, W., Li, C., Xiong, X. P., Zhu, J. Y., et al. (2015). Elevated level of circulating platelet-derived microparticles in Oral Cancer. J. Dent. Res. 95, 87-93. doi: 10.1177/0022034515592593
163. Rozmyslowicz, T., Majka, M., Kijowski, J., Murphy, S. L., Conover, D. O., Poncz, M., et al. (2003). Platelet-and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. Aids 17, 33-42. doi: 10.1097/00002030-200301030-00006
164. Sabatier, F., Darmon, P., Hugel, B., Combes, V., Sanmarco, M., Velut, J. G., et al. (2002). Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51, 2840-2845.
165. +T cells into T regulatory cells. Thromb. Haemost. 112, 1219-1229. doi: 10.1160/TH14-03-0281
166. Sadallah, S., Eken, C., Martin, P. J., and Schifferli, J. A. (2011). Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J. Immunol. 186, 6543-6552. doi: 10.4049/jimmunol.1002788
167. Sakariassen, K. S., Holme, P. A., Orvim, U., Barstad, R. M., Solum, N. O., and Brosstad, F. R. (1998). Shear-induced platelet activation and platelet microparticle formation in native human blood. Thromb. Res. 92(6 Suppl. 2), S33-S41. doi: 10.1016/S0049-3848(98)00158-3
168. Sambola, A., Osende, J., Hathcock, J., Degen, M., Nemerson, Y., Fuster, V., et al. (2003). Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107, 973-977. doi: 10.1161/01.CIR.0000050621.67499.7D
169. Santos-Gallego, C. G., Picatoste, B., and Badimon, J. J. (2014). Pathophysiology of acute coronary syndrome. Curr. Atheroscler. Rep. 16, 401. doi: 10.1007/s11883-014-0401-9
170. Sarlon-Bartoli, G., Bennis, Y., Lacroix, R., Piercecchi-Marti, M. D., Bartoli, M. A., Arnaud, L., et al. (2013). Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. J. Am. Coll. Cardiol. 62, 1436-1441. doi: 10.1016/j.jacc.2013.03.078
171. Setzer, F., Oberle, V., Blass, M., Moller, E., Russwurm, S., Deigner, H. P., et al. (2006). Platelet-derived microvesicles induce differential gene expression in monocytic cells: a DNA microarray study. Platelets 17, 571-576. doi: 10.1080/09537100600760244
172. Shai, E., Rosa, I., Parguina, A. F., Motahedeh, S., Varon, D., and Garcia, A. (2012). Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J. Proteomics 76 Spec. No, 287-296. doi: 10.1016/j.jprot.2012.02.030
173. Shan, L. Y., Li, J. Z., Zu, L. Y., Niu, C. G., Ferro, A., Zhang, Y. D., et al. (2013). Platelet-derived microparticles are implicated in remote ischemia conditioning in a rat model of cerebral infarction. CNS Neurosci. Ther. 19, 917-925. doi: 10.1111/cns.12199
174. Siljander, P., Carpen, O., and Lassila, R. (1996). Platelet-derived microparticles associate with fibrin during thrombosis. Blood 87, 4651-4663.
175. Sims, P. J., Wiedmer, T., Esmon, C. T., Weiss, H. J., and Shattil, S. J. (1989). Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J. Biol. Chem. 264, 17049-17057.
176. Sinauridze, E. I., Kireev, D. A., Popenko, N. Y., Pichugin, A. V., Panteleev, M. A., Krymskaya, O. V., et al. (2007). Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets. Thromb. Haemost. 97, 425-434.
177. Skeppholm, M., Mobarrez, F., Malmqvist, K., and Wallen, H. (2012). Platelet-derived microparticles during and after acute coronary syndrome. Thromb. Haemost. 107, 1122-1129. doi: 10.1160/TH11-11-0779
178. Sommeijer, D. W., Joop, K., Leyte, A., Reitsma, P. H., and ten Cate, H. (2005). Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes. J. Thromb. Haemost. 3, 1168-1171. doi: 10.1111/j.1538-7836.2005.01403.x
179. Stahl, A. L., Sartz, L., and Karpman, D. (2011). Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 117, 5503-5513. doi: 10.1182/blood-2010-09-309161
180. 3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in FH patients. Thromb. Haemost. 111, 111-121. doi: 10.1160/TH13-07-0612
181. Suades, R., Padro, T., Alonso, R., Mata, P., and Badimon, L. (2013). Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells indicating protection against cell activation. Thromb. Haemost. 110, 366-377. doi: 10.1160/TH13-03-0238
182. 142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis. Thromb. Haemost. 114, 1310-1321. doi: 10.1160/TH15-04-0325
183. Suades, R., Padro, T., and Badimon, L. (2015b). The role of blood-borne microparticles in inflammation and hemostasis. Semin. Thromb. Hemost. 41, 590-606. doi: 10.1055/s-0035-1556591
184. 235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients. J. Thromb. Haemost. 13, 1776-1786. doi: 10.1111/jth.13065
185. Suades, R., Padro, T., Crespo, J., Ramaiola, I., Martin-Yuste, V., Sabate, M., et al. (2016). Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time. Int. J. Cardiol. 202, 378-387. doi: 10.1016/j.ijcard.2015.09.011
186. Suades, R., Padro, T., Vilahur, G., and Badimon, L. (2012). Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb. Haemost. 108, 1208-1219. doi: 10.1160/TH12-07-0486
187. Takano, K., Asazuma, N., Satoh, K., Yatomi, Y., and Ozaki, Y. (2004). Collagen-induced generation of platelet-derived microparticles in whole blood is dependent on ADP released from red blood cells and calcium ions. Platelets 15, 223-229. doi: 10.1080/09537100410001682797
188. Tan, K. T., Tayebjee, M. H., Lynd, C., Blann, A. D., and Lip, G. Y. (2005). Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann. Med. 37, 61-66. doi: 10.1080/07853890410018943
189. Tan, M., Yan, H. B., Li, J. N., Li, W. K., Fu, Y. Y., Chen, W., et al. (2016). Thrombin stimulated platelet-derived exosomes inhibit platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Cell. Physiol. Biochem. 38, 2348-2365. doi: 10.1159/000445588
190. Tans, G., Rosing, J., Thomassen, M. C., Heeb, M. J., Zwaal, R. F., and Griffin, J. H. (1991). Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 77, 2641-2648.
191. Tehrani, S., Mobarrez, F., Antovic, A., Santesson, P., Lins, P. E., Adamson, U., et al. (2010). Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thromb. Res. 126, e225-e231. doi: 10.1016/j.thromres.2010.05.023
192. Terrisse, A. D., Puech, N., Allart, S., Gourdy, P., Xuereb, J. M., Payrastre, B., et al. (2010). Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J. Thromb. Haemost. 8, 2810-2819. doi: 10.1111/j.1538-7836.2010.04088.x
193. Toth, B., Nikolajek, K., Rank, A., Nieuwland, R., Lohse, P., Pihusch, V., et al. (2007). Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets 18, 515-521. doi: 10.1080/09537100701525843
194. Trzepizur, W., Martinez, M. C., Priou, P., Andriantsitohaina, R., and Gagnadoux, F. (2014). Microparticles and vascular dysfunction in obstructive sleep apnoea. Eur. Respir. J. 44, 207-216. doi: 10.1183/09031936.00197413
195. Tschuor, C., Asmis, L. M., Lenzlinger, P. M., Tanner, M., Harter, L., Keel, M., et al. (2008). In vitro norepinephrine significantly activates isolated platelets from healthy volunteers and critically ill patients following severe traumatic brain injury. Crit. Care 12, R80. doi: 10.1186/cc6931
196. Ueba, T., Haze, T., Sugiyama, M., Higuchi, M., Asayama, H., Karitani, Y., et al. (2008). Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome. Thromb. Haemost. 100, 280-285.
197. Ueba, T., Nomura, S., Inami, N., Nishikawa, T., Kajiwara, M., Iwata, R., et al. (2010). Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J. Atheroscler. Thromb. 17, 342-349. doi: 10.5551/jat.2964
198. van der Wal, A. C., and Becker, A. E. (1999). Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovasc. Res. 41, 334-344. doi: 10.1016/S0008-6363(98)00276-4
199. van der Wal, A. C., Becker, A. E., van der Loos, C. M., and Das, P. K. (1994). Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36-44. doi: 10.1161/01.CIR.89.1.36
200. 63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin. Chem. 52, 657-664. doi: 10.1373/clinchem.2005.057414
201. van Nispentot Pannerden, H., de Haas, F., Geerts, W., Posthuma, G., van Dijk, S., and Heijnen, H. F. (2010). The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 116, 1147-1156. doi: 10.1182/blood-2010-02-268680
202. Van Wijk, M. J., VanBavel, E., Sturk, A., and Nieuwland, R. (2003). Microparticles in cardiovascular diseases. Cardiovasc. Res. 59, 277-287. doi: 10.1016/s0008-6363(03)00367-5
203. Varon, D., Hayon, Y., Dashevsky, O., and Shai, E. (2012). Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration. Thromb. Res. 130(Suppl. 1), S98-S99. doi: 10.1016/j.thromres.2012.08.289
204. Vasina, E. M., Cauwenberghs, S., Feijge, M. A., Heemskerk, J. W., Weber, C., and Koenen, R. R. (2011). Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis. 2, e211. doi: 10.1038/cddis.2011.94
205. Vasina, E. M., Cauwenberghs, S., Staudt, M., Feijge, M. A., Weber, C., Koenen, R. R., et al. (2013). Aging-and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release. Am. J. Blood Res. 3, 107-123.
206. von Hundelshausen, P., and Weber, C. (2007). Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100, 27-40. doi: 10.1161/01.RES.0000252802.25497.b7
207. Weber, A., Koppen, H. O., and Schror, K. (2000). Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb. Res. 98, 461-466. doi: 10.1016/S0049-3848(00)00192-4
208. Wickman, G. R., Julian, L., Mardilovich, K., Schumacher, S., Munro, J., Rath, N., et al. (2013). Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs. Cell Death Differ. 20, 1293-1305. doi: 10.1038/cdd.2013.69
209. Wiedmer, T., Shattil, S. J., Cunningham, M., and Sims, P. J. (1990). Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 29, 623-632. doi: 10.1021/bi00455a005
210. Willis, G. R., Connolly, K., Ladell, K., Davies, T. S., Guschina, I. A., Ramji, D., et al. (2014). Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles. Hum. Reprod. 29, 2756-2763. doi: 10.1093/humrep/deu281
211. Windelov, N. A., Johansson, P. I., Sorensen, A. M., Perner, A., Wanscher, M., Larsen, C. F., et al. (2014). Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients. J. Trauma Acute Care Surg. 77, 692-700. doi: 10.1097/TA.0000000000000437
212. Xiao, H., Jepkorir, C. J., Harvey, K., and Remick, D. G. (2002). Thrombin-induced platelet microparticles improved the aggregability of cryopreserved platelets. Cryobiology 44, 179-188. doi: 10.1016/S0011-2240(02)00024-X
213. Xie, R. F., Hu, P., Wang, Z. C., Yang, J., Yang, Y. M., Gao, L., et al. (2015). Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells. Transfusion 55, 1051-1057. doi: 10.1111/trf.12952
214. Yano, Y., Kambayashi, J., Shiba, E., Sakon, M., Oiki, E., Fukuda, K., et al. (1994). The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem. J. 299(Pt. 1), 303-308. doi: 10.1042/bj2990303
215. Zhang, X., McGeoch, S. C., Johnstone, A. M., Holtrop, G., Sneddon, A. A., Macrury, S. M., et al. (2013). Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J. Thromb. Thrombolysis 37, 455-463. doi: 10.1007/s11239-013-1000-2